Microstructure Imaging

Brooklyn, NY  All United States companies → Founded 2018
Imaging AI Specialist Specialty-Focused AI
Neurology Neurosurgery Radiology
Radiology & Imaging AI
Early-stage (backed by Y Combinator, received grants from HHS) — Undisclosed, with grants totaling over $800,000 from SBIR awards

Products

MICSI-RMT
Microstructure Imaging, Inc.
Radiology & Imaging AI
MICSI-RMT is an FDA 510(k) cleared AI-powered software suite from Microstructure Imaging, Inc. that enhances diffusion and functional MRI image quality by reducing noise and improving the signal-to-noise ratio through a random matrix theory-based algorithm.

See all 1 product →

About Microstructure Imaging

Microstructure Imaging Inc. (MICSI) is a healthcare AI company focused on revolutionizing Magnetic Resonance Imaging (MRI) by enhancing image quality and diagnostic capabilities. The company’s core offering is the FDA 510(k) cleared MICSI-RMT software suite, which utilizes AI tools and biophysical models, specifically the MP-PCA denoising method, to significantly improve the signal-to-noise ratio (SNR) of diffusion and functional MRI. This technology aims to provide clearer images, reduce artifacts, and enable more precise parametric mapping, which can lead to a decreased need for repeat scans and improved diagnostic accuracy for clinicians and radiologists.

MICSI’s vision extends to transforming MRI into a non-invasive diagnostic tool capable of assessing the cellular microenvironment. By refining image acquisition and processing, the company seeks to push the boundaries of medical diagnostics, offering a more comprehensive view of the human body for earlier and more precise interventions. Their solutions are particularly impactful in neuroimaging, including brain and prostate imaging applications.

Focus Areas

MRI image quality enhancement denoising neuroimaging prostate imaging quantitative analysis of diffusion-weighted imaging reducing MRI scan time increasing MRI resolution Alzheimer's care

Business Intelligence

Key InvestorsY Combinator, HHS
PartnershipsNYU Langone Health (spinout)
TechnologyCloud-native (implied), Random Matrix Theory-based algorithm (MP-PCA denoising method), DICOM data routing, self-supervised AI (does not require external training data or high-performance GPUs)
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

MRI Image Quality & Efficiency
Microstructure Imaging specializes in significantly enhancing MRI image quality through advanced denoising techniques and increasing resolution, while simultaneously focusing on reducing MRI scan times. This dual approach aims to optimize both diagnostic clarity and operational throughput.
Advanced Neuroimaging & Alzheimer's Care
The company offers specialized solutions for neuroimaging, providing clearer insights into brain structures and pathologies. A key focus includes support for Alzheimer's care, aiming to improve diagnostic and monitoring capabilities for this condition.
Precision Prostate Imaging
Microstructure Imaging provides enhanced imaging capabilities specifically tailored for prostate studies, which is crucial for accurate diagnosis, staging, and treatment planning of prostate conditions.
Quantitative Diffusion-Weighted Imaging (DWI)
A core expertise lies in the quantitative analysis of Diffusion-Weighted Imaging (DWI). This provides objective, measurable data that aids in characterizing tissues, monitoring disease progression, and assessing treatment response beyond qualitative assessment.
Key Differentiators
Microstructure Imaging stands out by combining significant improvements in MRI image quality (denoising, resolution) with substantial reductions in scan time. Their strong emphasis on quantitative DWI analysis and specialized applications in critical areas like neuroimaging (including Alzheimer's care) and prostate imaging provides a comprehensive solution for advanced MRI needs.
Inferred Technology Stack
Based on their specializations, Microstructure Imaging likely leverages advanced signal processing algorithms, machine learning (ML) and deep learning (DL) techniques for image reconstruction and enhancement, and proprietary software platforms for quantitative analysis and seamless integration into clinical workflows.
Physician Tip

Physicians can leverage Microstructure Imaging's solutions to achieve higher diagnostic confidence through superior image quality and objective quantitative data, enabling earlier and more precise diagnoses. The reduced scan times can significantly improve patient comfort and throughput, allowing for more efficient scheduling and increased access to MRI services. For complex neuroimaging and prostate studies, their specialized enhancements provide critical detail for challenging cases and robust treatment planning. Consider integrating their solutions to maximize the utility and longevity of existing MRI equipment, potentially delaying the need for costly hardware upgrades and enhancing overall departmental efficiency.

Microstructure Imaging's solutions would ideally integrate seamlessly with existing MRI scanners (aiming for vendor-agnostic compatibility where possible) and Picture Archiving and Communication Systems (PACS) to ensure a smooth clinical workflow. Compatibility with Electronic Medical Records (EMR) systems for automated reporting and data transfer would also be a key consideration for comprehensive clinical adoption and data management.

Products by Microstructure Imaging

1 product in the directory

MICSI-RMT
Microstructure Imaging, Inc.
Radiology & Imaging AI
MICSI-RMT is an FDA 510(k) cleared AI-powered software suite from Microstructure Imaging, Inc. that enhances diffusion and functional MRI image quality by reducing noise and improving the signal-to-noise ratio through a random matrix theory-based algorithm.

Reviews & Opinions

No web reviews on file yet for Microstructure Imaging. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Microstructure Imaging.

Loading videos...

Videos load interactively. If none appear, search YouTube for Microstructure Imaging →

View all on YouTube

Press & Coverage

AuntMinnie
FDA grants MICSI 510(k) for brain MRI image enhancement algorithm
NYU Langone Health spinout Microstructure Imaging (MICSI) has secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its MICSI-RMT AI image enhancement software for brain MRI. The software is designed to enhance white-matter imaging using a random matrix theory-based algorithm.
2024-07
Business Wire
Microstructure Imaging Receives FDA Clearance for MICSI-RMT, Bringing Random Matrix Theory Denoising Into Clinical Practice
Microstructure Imaging, Inc. (MICSI) announced FDA 510k clearance for its MICSI-RMT software suite, which is designed to enhance MRI image quality and sets a new standard in neuroimaging. This clearance marks the clinical translation of advanced MRI research.
2024-07
Medical Product Outsourcing
Microstructure Imaging Gains FDA Clearance for MICSI-RMT
Microstructure Imaging, a YCombinator-backed NYU Langone Health spinout, has received FDA 510k clearance for its MICSI-RMT software suite, which is designed to enhance MRI image quality. The software employs a random matrix theory-based algorithm to significantly improve MRI image quality.
2024-07
Practical Patient Care
Microstructure Imaging gets FDA nod for MICSI-RMT software suite
Microstructure Imaging has received US FDA 510k clearance for the MICSI-RMT software suite, which uses an algorithm based on random matrix theory to enhance MRI image quality by leveraging redundancy within MRI exams. The software improves visualization of small structures in brain white matter.
2024-07
Y Combinator
Launch YC: MICSI (Microstructure Imaging)
MICSI is introducing an innovative image processing algorithm to decrease MRI scan time, increase image resolution, and unlock new diagnostic capabilities using Microstructure Imaging. Their patented approach uses a self-supervised AI method to learn noise properties and remove noise uniformly.
2023-08
HHS TAGGS
2025 Tissue Microstructure Imaging Gordon Research Conference and Gordon Research Seminar
The National Cancer Institute is providing an award for the 2025 Tissue Microstructure Imaging Gordon Research Conference and Gordon Research Seminar, scheduled from July 21, 2025, to June 30, 2026. This conference focuses on advancing the understanding of tissue microstructure in physiology, pathology, development, aging, diagnosis, and treatment response.
2025-07
MDPI
Diffusion Microstructure Imaging to Analyze Perilesional T2 Signal Changes in Brain Metastases and Glioblastomas
This study explores the use of Diffusion Microstructure Imaging (DMI) to differentiate glioblastomas and brain metastases by analyzing alterations in T2 hyperintense areas surrounding tumor components. The methodology shows promise in microstructural characterization of brain tumors and has high diagnostic potential.
2022-02
Magnetic Resonance in Medicine
Combined diffusion-relaxometry microstructure imaging: Current status and future prospects
This article reviews combined diffusion-relaxometry imaging, an emerging paradigm in microstructure imaging that aims to noninvasively measure and map microscopic tissue features with more detail. This approach can disentangle multiple tissue compartments indistinguishable with single-contrast scans.
2021-12

Frequently Asked Questions

MICSI's FDA-cleared MICSI-RMT software suite utilizes a random matrix theory-based algorithm to significantly improve the signal-to-noise ratio (SNR) in diffusion and functional MRI, leading to enhanced image clarity and reduced artifacts. For neuroimaging, this translates to improved visualization of small brain white matter structures and more anatomically appropriate fMRI activation maps, while for prostate imaging, it offers a unique approach to address inefficient diffusion acquisition.
Yes, by significantly enhancing image quality and SNR, MICSI-RMT can enable the acquisition of higher effective resolution images or allow for faster scan times without compromising diagnostic quality. The company's broader vision is to transform MRI into a truly quantitative instrument, capable of providing higher resolution data with faster acquisition, with MICSI-RMT being a foundational step towards this goal.
MICSI-RMT includes processing modules that support weighted linear least squares and Bayesian fitting techniques, facilitating quantitative analysis of diffusion-weighted imaging and improving the precision of ADC maps by over 56.3%. Additionally, MICSI-PET is currently in clinical validation to provide fast, anatomical, and scalable PET imaging, specifically designed to address the bottleneck in amyloid PET scans crucial for the diagnosis and management of Alzheimer's disease.
Microstructure Imaging demonstrates its commitment to regulatory compliance through its FDA 510k clearance for the MICSI-RMT software suite. The software also features advanced DICOM data routing to ensure secure and seamless integration into existing medical workflows. While specific details on support and training programs are not publicly detailed, comprehensive technical assistance and educational resources are typically provided to ensure effective clinical implementation and user proficiency.
While specific pricing models are not publicly disclosed, Microstructure Imaging aims to make MRI more accessible and cost-effective, potentially by extending the lifecycle of older MR systems through enhanced image quality. The company, a YCombinator-backed NYU Langone Health spinout founded in 2018, is actively advised by globally recognized experts in MRI physics, indicating a strong foundation and potential for strategic partnerships to further its mission.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.